Cetaphil® Skin Care Products
March 2017: This action was dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed.
September 2016: A false advertising class-action lawsuit was filed against Galderma Laboratories in September 2016 (and transferred to federal court in October 2016) for allegedly misleadingly representing that Cetaphil® skin care products treat or mitigate eczema when, in reality, they do not. (Greenberg et al v. Galderma Laboratories, L.P. and Does 1-100, Case No. 16-cv-6090, N. D. CA.)
Class-Action Tracker
The Latest
BART
Why “taking BART” from Oakland to San Francisco costs more than advertised in this billboard.
Breaking Down the Relationship between Brands and Teens
Today’s teenagers are uniquely positioned in the marketing world.
FTC Bans Fake Reviews
New rule also targets paid reviews.
Virgin Atlantic: ‘100% Sustainable Aviation Fuel’
Ad regulator finds term potentially misleading in context of radio ad.
College HUNKS’ Unattractive Side
TINA.org reader says moving company failed to live up to its ads. She’s not the only one.